Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ryaltris vs Patanase vs Nasonex in seasonal allergic rhinitis
CTR20213407Phase 3Completed
- Sponsor
- Glenmark Pharmaceuticals
- Start
- Dec 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mometasone in seasonal allergic rhinitis (SAR), allergic rhinoconjunctivitis (ARC), sponsored by Glenmark Pharmaceuticals. Started Dec 2021; status: completed.
02
Drugs
mometasone
03
Conditions
seasonal allergic rhinitis (SAR)allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on CTR20213407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20213407.